Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Opko Health
Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else
Almost 80% of novel agent submissions from the biggest companies were approved in recent years, compared with a 60% approval rate for the rest of the industry, according to a Pink Sheet analysis of FDA approval decisions since 2021.
Biopharma Industry Sharply Divided Over Supreme Court Antibody Patent Brawl
Big biologic makers line up on opposite sides of dispute between Amgen and Sanofi over whether Amgen’s Repatha patents cover analogous antibodies with the same functional characteristics.
Scrip Asks...What Does 2023 Hold For Biopharma? Part 2: M&A And Partnering
Deal-making between big pharma and biotech looks set to rise with a looming patent cliff increasing the need for the former to replenish its pipelines. Meanwhile, biotechs need partners to help them advance amid the ongoing big freeze on raising cash on public markets.
Dealmaking Quarterly Statistics, Q2 2022
During Q2, biopharma merger and acquisition value reached $25.4bn and drew in $27.3bn in potential deal value from alliances. Device company M&A values reached $2.7bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $534.3m.
- Drug Delivery
- Generic Drugs
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
Laboratory Testing Services
- Anatomical Pathology
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
- Therapeutic Drug Monitoring
- Antisense, Oligonucleotides
- Large Molecule
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Other Names / Subsidiaries
- ALS Distribuidora Limitada
- Bio-Reference Laboratories, Inc.
- Claros Diagnostics Inc.
- CURNA, Inc.
- Cytochroma, Inc.
- EirGen Pharma, Ltd.
- eXegenics, Inc.
- Inspiro Medical Ltd.
- PROLOR Biotech, Inc.
- Prost-Data, Inc.
- Silcon Comércio
- Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda.
- Transition Therapeutics Inc.
- Waratah Pharmaceuticals Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.